Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic

E Deutsch1, M Berger, W G Kussmaul

  • 1Department of Medicine, University of Pennsylvania, School of Medicine, Philadelphia.

Circulation
|December 1, 1990
PubMed

Insights

Second coronary artery occlusions during angioplasty show reduced ischemia. This suggests the heart adapts to brief periods of reduced blood flow, a phenomenon known as ischemic preconditioning.

Area of Science:

  • Cardiology
  • Physiology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) involves temporary coronary artery occlusion.
  • Understanding the heart's response to repeated ischemia is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the clinical, electrocardiographic, and hemodynamic responses to sequential coronary artery occlusions during PTCA.
  • To examine myocardial lactate metabolism during repeated occlusions.

Main Methods:

  • 12 patients undergoing PTCA had sequential 90-second occlusions of the left anterior descending coronary artery.
  • Myocardial lactate metabolism was assessed in a separate group of 7 patients.

Main Results:

  • The second occlusion caused less anginal discomfort, ST segment shift, and lower pulmonary artery pressure compared to the first.
  • Cardiac vein flow and myocardial lactate production were significantly reduced during the second occlusion.
  • These findings indicate a protective adaptation to ischemia.

Conclusions:

  • Reduced evidence of myocardial ischemia during the second occlusion supports the concept of ischemic preconditioning.
  • Ischemic preconditioning may offer a protective mechanism during interventional procedures like PTCA.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...